Equillium To Advance New Aryl Hydrocarbon Receptor Modulator Development Program for EQ504

Equillium, Inc. is advancing its novel and potent aryl hydrocarbon receptor (AhR) modulator (EQ504) development program.
Equillium, Inc. is advancing its novel and potent aryl hydrocarbon receptor (AhR) modulator (EQ504) development program.